Identification of ciprofloxacin-resistant Campylobacter jejuni and analysis of the gyrA gene by the LightCycler mutation assay

被引:29
作者
Dionisi, AM [1 ]
Luzzi, I [1 ]
Carattoli, A [1 ]
机构
[1] Ist Super Sanita, Lab Bacteriol & Med Mycol, I-00161 Rome, Italy
关键词
Campylobacter; real-time PCR; ciprofloxacin resistance; gyrA mutation;
D O I
10.1016/j.mcp.2004.02.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A real-time PCR assay was developed to identify ciprofloxacin-resistant Campylobacter jejuni. Ciprofloxacin resistance in C. jejuni has been associated with a C --> T nucleotide point mutation occurring at the 86 codon of the gyrA gene. Other nucleotide substitutions have been identified in proximity to or at the same codon in the gyrA gene, but their role in ciprofloxacin resistance is still unknown. The LightCycler assay is based on the fluorescence resonance energy transfer technology using melting peak analysis of two fluorescent probes hybridized on PCR amplicons. This assay was used to detect the 86-codon mutation conferring ciprofloxacin resistance, as well as other nucleotides substitutions occurring within the same site in the gyrA gene. This gyrA mutation assay allows a rapid and reproducible screening method of ciprofloxacin resistant strains and was applied to C. jejuni strains isolated in Italy in 2000. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 26 条
  • [1] [Anonymous], 1999, Clin Microbiol Infect, V5, P239, DOI 10.1111/j.1469-0691.1999.tb00135.x
  • [2] [Anonymous], [No title captured]
  • [3] THE E-TEST AND CAMPYLOBACTER-JEJUNI
    BAKER, CN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (05) : 469 - 472
  • [4] Balfour J A, 1993, Pharmacoeconomics, V3, P398, DOI 10.2165/00019053-199303050-00007
  • [5] Carattoli A, 2002, FEMS MICROBIOL LETT, V214, P87, DOI 10.1111/j.1574-6968.2002.tb11329.x
  • [6] EVIDENCE FOR AN EFFLUX PUMP IN MULTIDRUG-RESISTANT CAMPYLOBACTER-JEJUNI
    CHARVALOS, E
    TSELENTIS, Y
    HAMZEHPOUR, MM
    KOHLER, T
    PECHERE, JC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) : 2019 - 2022
  • [7] Charvalos E, 1996, J CLIN LAB ANAL, V10, P129, DOI 10.1002/(SICI)1098-2825(1996)10:3<129::AID-JCLA3>3.0.CO
  • [8] 2-6
  • [9] Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates
    Engberg, J
    Aarestrup, FM
    Taylor, DE
    Gerner-Smidt, P
    Nachamkin, I
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (01) : 24 - 34
  • [10] Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter
    Ge, B
    Bodeis, S
    Walker, RD
    White, DG
    Zhao, S
    McDermott, PF
    Meng, JH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (04) : 487 - 494